GI Innovation, Inc. 358570.KQ
358570.KQ
GI Innovation, Inc. 085660.KQ
Chabiotech Co.,Ltd. 086900.KQ
Medy-Tox Inc. 950210.KS
Prestige BioPharma Limited 476060.KQ
Onconic Therapeutics 475830.KQ
Orum Therapeutics, Inc. 005690.KS
Pharmicell Co., Ltd. 005257.KS
Green Cross Holdings Corporation 005250.KS
Green Cross Holdings Corporation 226950.KQ
OliX Pharmaceuticals,Inc
GI Innovation, Inc. 085660.KQ
Chabiotech Co.,Ltd. 086900.KQ
Medy-Tox Inc. 950210.KS
Prestige BioPharma Limited 476060.KQ
Onconic Therapeutics 475830.KQ
Orum Therapeutics, Inc. 005690.KS
Pharmicell Co., Ltd. 005257.KS
Green Cross Holdings Corporation 005250.KS
Green Cross Holdings Corporation 226950.KQ
OliX Pharmaceuticals,Inc
Performance
| Periode | 358570.KQ | 085660.KQ | 086900.KQ | 950210.KS | 476060.KQ | 475830.KQ | 005690.KS | 005257.KS | 005250.KS | 226950.KQ |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -3.87 % | 4.64 % | -26.15 % | -14.68 % | -31.13 % | 28.28 % | 33.76 % | 24.06 % | 17.51 % | 85.46 % |
| YTD | 97.65 % | 0.53 % | -0.17 % | -18.46 % | 22.95 % | 61.24 % | 64.87 % | 13.85 % | -3.83 % | 397.89 % |
| 1Y | 20.53 % | -36.98 % | -30.60 % | -16.11 % | 10.87 % | 61.24 % | 156.57 % | 3.54 % | -5.64 % | 225.52 % |
| 3Y | 49.73 % | -13.56 % | 22.30 % | 69.84 % | 10.87 % | 61.24 % | 42.84 % | -33.92 % | -3.29 % | 403.47 % |
| 5Y | 49.73 % | -36.81 % | -20.52 % | -75.00 % | 10.87 % | 61.24 % | -18.86 % | -81.35 % | -29.39 % | 196.86 % |
| 10Y | 49.73 % | -24.80 % | -66.63 % | -75.00 % | 10.87 % | 61.24 % | 161.55 % | 7.35 % | -59.19 % | 196.86 % |
| Depuis le début | 49.73 % | 51.14 % | 886.68 % | -75.00 % | 10.87 % | 61.24 % | 4 780.43 % | 708.10 % | 283.58 % | 196.86 % |